Dishman Pharmaceuticals & Chemicals Ltd.

BSE: 532526
₹301.05
▲ 31.95 (11.87%)
May 29, 2017 · BSE · bse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
51/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
40.1
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
Data unavailable.
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Ownership

1 of 2 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter

Value and momentum

1 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
11.9%
Low 278.1000 · High 304.3000
1W return
3.5%
Low 263.1000 · High 304.3000
1M return
-3.1%
Low 263.1000 · High 322.4000
52W return
96.4%
Low 127.6000 · High 346.2500
Lifetime High ₹410.6500 (Jan. 4, 2008)
Lifetime Low ₹34.7000 (Dec. 16, 2011)

Full price history and technicals →

EMA & SMA

Bullish6
Bearish0
5D
290.3
10D
294.6
20D
298.6
50D
287.1
100D
266.0
200D
233.2

Delivery and volume

Day avg. delivery
13.1%
Week avg. delivery
16.3%
Month avg. delivery
19.6%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

294.48
Pivot
First resistance310.87
Second resistance320.68
Third resistance337.07
First support284.67
Second support268.28
Third support258.47
Day RSI51.7
Day MFI40.5
Day MACD-1.73
Day MACD signal2.52

Beta

1M3.38
3M2.50
1Y1.31
3Y1.27

Price change analysis

↓ -3.1%
Over 1 Month
LowHigh
263.10322.40
↑ 33.0%
Over 3 Months
LowHigh
220.50346.25
↑ 25.6%
Over 6 Months
LowHigh
200.10346.25
↑ 96.4%
Over 1 Year
LowHigh
127.60346.25
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Data unavailable.

Shareholding pattern / Ownership

Shareholding summary

Mar 2017
  • Promoter61.40%
  • Mutual funds9.57%
  • FII/FPI10.57%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 61.40% in Mar 2017 qtr

Historical fii holding

FII/FPI holdings decreased from 11.97% to 10.57% in Mar 2017 qtr

Historical mutual fund holding

Mutual funds holdings increased from 7.69% to 9.57% in Mar 2017 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
31 Aug 2007 UBS SECURITIES ASIA LTD Bulk Sell 430,000 284.2200 BSE
19 Feb 2007 GOLDMAN SACHS INVESTMENTS Bulk Sell 450,000 233.6600 BSE
28 Mar 2006 THE MASTER TRUST BANK OF Bulk Buy 749,704 190.0000 BSE
28 Mar 2006 HDFC TRUSTEE COMPANY LTD Bulk Sell 750,000 190.0000 BSE
1 Feb 2006 THE MASTER TRUST BANK OF Bulk Buy 1,006,920 190.0000 BSE
1 Feb 2006 BHADRA RAJ HOLDINGS PVT L Bulk Sell 1,009,850 190.0100 BSE
31 Jan 2006 RAJNIKANT T VYAS Bulk Sell 1,500,000 190.0000 BSE
31 Jan 2006 THE MASTER TRUST BANK OF Bulk Buy 1,500,000 190.0000 BSE
15 Sep 2005 MORGAN STANLEY AND CO AC Bulk Buy 74,662 734.0000 BSE
15 Sep 2005 LLOYD GEORGE INVESTMENT M Bulk Sell 157,441 734.0000 BSE

All bulk and block deals →

Last 12 months ₹1.20 per share
Dividend yield 0.40%
Ex-dateSubjectPer share (₹)Record date
17 Feb 2017 Interim Dividend Rs 1.20 Per Share (Purpose Revised) 1.2000 21 Feb 2017
17 Mar 2016 Interim Dividend - Rs 2/- Per Share (Purpose Revised) 2.0000 18 Mar 2016
10 Sep 2015 Annual General Meeting/Dividend - Rs 2/- Per Share 2.0000 —
21 Aug 2014 Annual General Meeting / Final Dividend - Rs 1.20/- Per Share 1.2000 —
18 Jul 2013 Annual General Meeting And Dividend Rs.1.20 Per Share 1.2000 —
13 Sep 2012 Annual General Meeting/Dividend Rs.1.20 Per Share 1.2000 —
14 Jul 2011 Annual General Meeting And Dividend Rs.1.20 Per Share 1.2000 —
15 Jul 2010 Annual General Meeting And Dividend Rs.1.20 Per Share 1.2000 —
17 Jul 2008 Agm/Dividend-50% — —
26 Jul 2007 Agm/Dividend-50% — —

Corporate Actions

Full history (15 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
2 May 2016BONUS Bonus 1:1
16 Sep 2016OTHER Annual General Meeting
14 Jul 2009AGMAgm/Div-Rs.1.20 Per Share

All corporate actions →

Corporate Announcements

All 231 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
22 May 2017 Suspension of Trading DISHMAN: Members of the Exchange are hereby informed that the trading in Equity Shares of Dishman Pharmaceuticals and Chemicals Limited shall be suspended w.e.f. May 30, 2017 (i.e. closing hours of trading on May 29, 2017) on account of Scheme of Amalgamation of Dishman Pharmaceuticals and Chemicals Limited with Carbogen Amcis (India) Limited.
19 May 2017 Record Date Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the Board of directors of Amalgamated entity i.e Dishman Carbogen Amcis Limited, in its meeting held on May 19, 2017 has fixed Record Date as May 31, 2017 for the purpose of deciding the members who shall be eligible for allotment of equity shares of the amalgamated entity, Dishman Carbogen Amcis Limited to the shareholders of erstwhile Dishman Pharmaceuticals and Chemicals Limited ("DPCL") in the ratio of 1:1 i.e. Share Exchange Ratio [1 (One) fully paid-up Equity Share of Rs.2/- (Rupees Two only) each of DCAL, for every 1 (One) fully paid-up Equity Share of Rs.2/ (Rupees Two only) each held by such shareholder in DPCL], fixed under the Scheme of Arrangement and Amalgamation approved by the Hon'ble High Court of Gujarat.
17 May 2017 Investor Presentation Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Investor Presentation
16 May 2017 Financial Result Updates Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2017.
15 May 2017 Analysts/Institutional Investor Meet/Con. Call Updates Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
8 May 2017 Trading Window Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
18 Apr 2017 Credit Rating Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Credit Rating
10 Apr 2017 Disc. under Reg.30 of SEBI (SAST) Reg.2011 Bhadra Raj Holdings Private Limited has submitted to the Exchange vide letter dated April 06, 2017 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
6 Apr 2017 Disclosure under SEBI Takeover Regulations Bhadra Raj Holdings Pvt Ltd has submitted to the Exchange, vide letter dated April 5, 2017 a copy of disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
28 Mar 2017 News Verification The Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Limited with respect to recent news item captioned "US FDA Approves Zejula Capsules.". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Dishman Pharmaceuticals and Chemicals Limited has submitted their response.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Dishman Pharmaceuticals & Chemicals Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.